Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Revista de Salud Pública
versión impresa ISSN 0124-0064
Resumen
MACHADO-ALBA, Jorge E. et al. Monitoring and impact of the disclosure of five health alerts for drugs in Colombia. Rev. salud pública [online]. 2018, vol.20, n.1, pp.23-26. ISSN 0124-0064. https://doi.org/10.15446/rsap.v20n1.56884.
Objective
Make the notification and monitoring compliance with five health drug alerts to a group of health care providers in Colombia.
Methods
Quasi-experimental, prospective, before-after study, without control group, by intervening in physician prescribers of ketoconazole, metoclopramide, nimesulide, diacerein, strontium ranelate. The affiliated population of the contributory system of the Colombian Health System was taken as the universe population sample from 13 health promoting entities (EPS) of Colombia. Patients receiving monthly these drugs prior to the alert were identified. An educational intervention was performed and then the rate of change in the dispensation was measured.
Results
About 26 different activities were conducted on 500 prescribers. Out of a total of 4 121 954 people, 13 979 patients were identified monthly in 2013, who received some of the five medications. Likewise, a reduction in 1,470 subjects per month (-10.5%) for 2014 was observed. The drug which achieved the greatest reduction was ketoconazole (-31.1% of cases), followed by strontium ranelate (-30.3%) and metoclopramide (-8.6%). For nimesulide (+ 0.7%) and diacerein (+ 16.4%) no favorable results were obtained.
Conclusions
Patients with potentially risky prescriptions remain in Colombia; educational pharmacovigilance interventions made after the report alerts given by drug regulatory agencies may decrease the proportion of patients using these drugs.
Palabras clave : Pharmacovigilance; deprescriptions; ketoconazole; metoclopramide (source: MeSH, NLM).